drugset / Trial / NCT00330070
Control of Asthma Patients Symptomatic on Inhaled Corticosteroids
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study is to determine whether IPL512,602 is safe and effective for the treatment of asthma symptoms in patients who remain symptomatic on a background therapy of inhaled corticosteroids.
Timeline
- Start
- 2006-05
- Primary completion
- —
- Completion
- 2007-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IPL512,602 | Unknown | 20 mg | Oral |